Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials

Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System

(2017) Venkatesh Ponemone et al.   Stem Cells International

Below-The-Knee Angioplasty for Critical Limb Ischemia: Results of a Series of 157 Procedures and Impact of the Angiosome Concept

(2016) Marie Pavé et al.   ANNALS OF VASCULAR SURGERY

Comparison of angioplasty and bypass surgery for critical limb ischaemia in patients with infrapopliteal peripheral artery disease

(2016) S. D. Patel et al.   BRITISH JOURNAL OF SURGERY

Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia

(2015) Jan Skóra et al.   Archives of Medical Science

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) Trial

(2015) M. Teraa et al.   CIRCULATION

Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials

(2015) S.M.O. Peeters Weem et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Cell Therapy in Patients with Critical Limb Ischemia

(2015) Rita Compagna et al.   Stem Cells International

Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial

(2014) Amish N. Raval et al.   CYTOTHERAPY

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population

(2014) Mark R. Nehler et al.   JOURNAL OF VASCULAR SURGERY

Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease—results of the short- and long-term follow-up

(2013) Gábor Viktor Szabó et al.   CYTOTHERAPY

Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment

(2013) M. Dubsky et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Therapeutic Outcomes of Transplanting Autologous Granulocyte Colony-stimulating Factor-mobilised Peripheral Mononuclear Cells in Diabetic Patients with Critical Limb Ischaemia

(2013) L. Mohammadzadeh et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Autologous Bone Marrow Mononuclear Cells Transplant in Patients With Critical Leg Ischemia: Preliminary Clinical Results

(2013) Min Li et al.   Experimental and Clinical Transplantation

Stem cells of the lower limb: Their role and potential in management of critical limb ischemia

(2013) Colin A Hart et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

(2013) Pawan K Gupta et al.   Journal of Translational Medicine

Bone Marrow Alterations and Lower Endothelial Progenitor Cell Numbers in Critical Limb Ischemia Patients

(2013) Martin Teraa et al.   PLoS One

Stem Cell Therapy for Lower Extremity Diabetic Ulcers: Where Do We Stand?

(2013) Mei Yang et al.   Biomed Research International

A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia

(2012) Douglas W. Losordo et al.   Circulation-Cardiovascular Interventions

Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia

(2012) Ahmet Ozturk et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Cellular Therapy With Ixmyelocel-T to Treat Critical Limb Ischemia: The Randomized, Double-blind, Placebo-controlled RESTORE-CLI Trial

(2012) Richard J Powell et al.   MOLECULAR THERAPY

Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia

(2011) Dirk H. Walter et al.   Circulation-Cardiovascular Interventions

Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial

(2011) Debin Lu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Chapter I: Definitions, Epidemiology, Clinical Presentation and Prognosis

(2011) F. Becker et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design

(2011) Eric Benoit et al.   Journal of Translational Medicine

Combination Stem Cell Therapy for the Treatment of Severe Limb Ischemia: Safety and Efficacy Analysis

(2010) Gabriel P. Lasala et al.   ANGIOLOGY

Cell Therapy, a New Standard in Management of Chronic Critical Limb Ischemia and Foot Ulcer

(2010) V. Procházka et al.   CELL TRANSPLANTATION

Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment

(2010) Ralf W. Sprengers et al.   JOURNAL OF VASCULAR SURGERY

Treatment of peripheral arterial disease using stem and progenitor cell therapy

(2010) Holger Lawall et al.   JOURNAL OF VASCULAR SURGERY

Targeting Nonhealing Ulcers of Lower Extremity in Human Through Autologous Bone Marrow-Derived Mesenchymal Stem Cells

(2009) Nihar Ranjan Dash et al.   REJUVENATION RESEARCH